Get started
Author

Bérenger Largeau

Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases
2017 · Anne-Claire Dupont, Bérenger Largeau, et al. · International Journal of Molecular Sciences · 194
Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations
2017 · Claire Tronel, Bérenger Largeau, et al. · International Journal of Molecular Sciences · 161
PDF
Drug‐induced peripheral oedema: An aetiology‐based review
2021 · Bérenger Largeau, Jean‐Luc Cracowski, et al. · British Journal of Clinical Pharmacology · 89
PDF
TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases?
2017 · Bérenger Largeau, Anne-Claire Dupont, et al. · Contrast Media & Molecular Imaging · 57
PDF
Arginine Vasopressin and Posterior Reversible Encephalopathy Syndrome Pathophysiology: the Missing Link?
2019 · Bérenger Largeau, Olivier Le Tilly, et al. · Molecular Neurobiology · 50
Posterior Reversible Encephalopathy Syndrome in Clinical Toxicology: A Systematic Review of Published Case Reports
2020 · Bérenger Largeau, David Boels, et al. · Frontiers in Neurology · 36
PDF
Ischemia/reperfusion-associated tubular cells injury in renal transplantation: Can metabolomics inform about mechanisms and help identify new therapeutic targets?
2018 · Chantal Barin-Le Guellec, Bérenger Largeau, et al. · Pharmacological Research · 30
Sex differences in adverse drug reactions: Are women more impacted?
2022 · Clémence Lacroix, Anaïs Maurier, et al. · Therapies · 29
Gabapentinoid-induced peripheral edema and acute heart failure: A translational study combining pharmacovigilance data and in vitro animal experiments
2022 · Bérenger Largeau, Romain Bordy, et al. · Biomedicine & Pharmacotherapy · 27
PDF
Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels
2022 · Bérenger Largeau, Arnaud Karam, et al. · European Journal of Neurology · 26
The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases
2018 · Anne-Claire Dupont, Bérenger Largeau, et al. · Contrast Media & Molecular Imaging · 26
PDF
Experimental Models of Posterior Reversible Encephalopathy Syndrome: A Review From Pathophysiology to Therapeutic Targets
2023 · Bérenger Largeau, Sandrine Bergeron, et al. · Stroke · 21
COVID-19 Vaccination as a Trigger of IgA Vasculitis: A Global Pharmacovigilance Study
2022 · Yanis Ramdani, Bérenger Largeau, et al. · The Journal of Rheumatology · 21
PDF
The safety profile of fluoroquinolones
2025 · Annie-Pierre Jonville-Béra, Bérenger Largeau, et al. · Infectious Diseases Now · 16
Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial
2022 · A. Marchand, A. Caille, et al. · Trials · 15
PDF
Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity
2018 · Benjamin Anon, Bérenger Largeau, et al. · Cancer Chemotherapy and Pharmacology · 14
Single nucleotide polymorphisms of ABCC2 modulate renal secretion of endogenous organic anions
2017 · Kienana Muhrez, Bérenger Largeau, et al. · Biochemical Pharmacology · 12
Immune checkpoint inhibitor–associated capillary leak syndrome: A systematic review and a worldwide pharmacovigilance study
2023 · Jonathan Wong So, Fatma Bouibede, et al. · Journal of Internal Medicine · 10
PDF
Specific features of amoxicillin‐associated Drug Reaction with Eosinophilia and Systemic Symptoms syndrome: a nationwide study
2021 · B. Largeau, M.‐S. Agier, et al. · Journal of the European Academy of Dermatology and Venereology · 8
Pazopanib-induced posterior reversible encephalopathy syndrome with possible syndrome of inappropriate secretion of antidiuretic hormone: an incidental or pathophysiological association?
2019 · Jonathan Wong So, Bérenger Largeau, et al. · Neural Regeneration Research · 8
Thrombotic microangiopathy associated with anticancer and immune system targeting drugs: New insights from real‐world data using the WHO pharmacovigilance database
2023 · Bérenger Largeau, Benjamin Thoreau, et al. · Journal of Internal Medicine · 7
PDF
Comparison of Tacrolimus Starting Doses Based on CYP3A5 Phenotype or Genotype in Kidney Transplant Recipients
2019 · Bérenger Largeau, Chantal Barin-Le Guellec, et al. · Progress in Transplantation · 7
Drug clustering to anticipate new aspects of drug safety profile: Application to gabapentinoids and other voltage‐gated calcium channel ligand drugs
2023 · Thibault Viguier, Marie‐Sara Agier, et al. · British Journal of Clinical Pharmacology · 5
PDF
Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series
2023 · Morgane Chamboux, Corinne Simon, et al. · Therapies · 5
Teriflunomide‐associated urolithiasis: a new adverse reaction explained by its uricosuric effect
2021 · Bérenger Largeau, Frédéric Béra, et al. · Fundamental and Clinical Pharmacology · 2
Works count: 37
Citation count: 878
H-index: 15
I10-index: 18
Year
Topic
Type